Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Somatogen initiates phase II Optro trial for new indication

May 2, 1997

Ethical initiates U.S. pivotal trials of HRT combination patch

May 2, 1997

Fluvastatin safe and effective in hypercholesterolemic patients on probucol

April 30, 1997

New treatment for Wilson's disease now available

April 30, 1997

TheraTech reacquires marketing rights to testosterone patch product

April 29, 1997

Axcan receives IND approval for URSO in hypercholesterolemia

April 28, 1997

Glaxo Wellcome discovers potent BAT inhibitor

April 28, 1997

Exactech and the University of Florida Tissue Bank to codevelop biologic bone repair material

April 28, 1997

Potent, selective beta3-agonist from Merck & Co.

April 25, 1997

Amino-ketones from Roche found to lower cholesterol levels in animals

April 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.